Stem cell community loses a treasured friend

by Guest | Jan 18, 2016

Joe Sornberger is Director of Communications Programs for the Canadian Stem Cell Foundation and author of Dreams & Due Diligence: Till and McCulloch’s Stem Cell Discovery and Legacy. This post is published here with his permission. The stem cell community is...

Right Turn: New $40M centre will solve cell therapy manufacturing challenges

by Stacey Johnson | Jan 15, 2016

It was huge news in Canada on Wednesday (January 13) when the Centre for Commercialization of Regenerative Medicine (CCRM) and GE Healthcare announced their partnership in the development of a new centre for advanced therapeutic cell technologies. GE Healthcare is...

Gene Therapy To Treat HIV In Clinical Trial

by Guest | Jan 14, 2016

John Farrell is a science and technology blogger for Forbes online. John was invited to cover proceedings at the 2015 Till & McCulloch Meetings and this is his second report. This blog also appears on Forbes and is reprinted here with permission. One of the more...

Right Turn: “Rock star” researcher awarded $2.4 million to create new skin

by Stacey Johnson | Jan 8, 2016

Jakub Tolar, the University of Minnesota researcher who shared stage time with Pearl Jam’s Eddie Vedder, has been awarded $2.4 million, by the Schulze Family Foundation, to support his work creating new skin for people suffering from burns and skin diseases, such as...

An interview with bioengineering pioneer Kevin Healy

by Hamideh Emrani | Jan 5, 2016

In the fourth in her series on “What drives research in the field of biomaterials?” blogger Hamideh Emrani interviews Professor Kevin E. Healy at the University of California, Berkeley. You can catch up on Hamideh’s earlier interviews here. I met Professor Kevin Healy...

Right Turn: Happy New Year to you!

by Stacey Johnson | Jan 1, 2016

Thank you, loyal readers, for making 2015 a great year for Signals! All the bloggers here at Signals wish you a very happy 2016. Please keep stopping by to read our content and let us know what you think. We’re grateful that you’re reading us and sharing our content,...

Cell Therapy Deal Review: November

by Mark Curtis | Dec 30, 2015

Welcome to your Cell Therapy Deal Review for the month of November. Astellas failed to achieve the majority share it needed to push through a takeover of Ocata Therapeutics valued at $379 million. ImmunoCellular Therapeutics announced a research agreement with MD...

ISCT webinar: Reimbursement re-cap

by Mark Curtis | Dec 28, 2015

For those of you that missed ISCT’s recent webinar on manufacturing, needle-to-needle logistics and reimbursement, below is a brief re-cap of the key points on the reimbursement section that I provided. The presentation, including audio, should be available free on...

Rudolph, red noses and regeneration

by Guest | Dec 21, 2015

Samantha Payne is a PhD student in the Chemical Engineering and Applied Chemistry department at the University of Toronto. She has previously investigated regeneration in a non-mammalian gecko model during an MSc program, and now currently combines stem cell biology...

Right Turn: The official Signals Gift Giving Guide

by Guest | Dec 18, 2015

Emily Easto, communications specialist for the Centre for Commercialization of Regenerative Medicine (CCRM), is making her Signals debut here. If you like her list, we can probably coax her into making it a yearly offering. While publishing a gift guide so late in the...